Butterfly gliomas: to biopsy or to ablate – a longitudinal cohort study - Scorecard - MDSpire

Butterfly gliomas: to biopsy or to ablate – a longitudinal cohort study

  • By

  • Vratko Himic

  • Morgan Leigh Johnson

  • Anshul Ratnaparkhi

  • Roxanne C. Mayrand

  • Jay Chandar

  • Vaidya Govindarajan

  • Daniel C. Kreatsoulas

  • Arman Jahangiri

  • Zachary C. Gersey

  • Daniel M. Aaronson

  • Ricardo J. Komotar

  • Micheal E. Ivan

  • Ashish H. Shah

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: Biopsy versus Ablation in Butterfly Gliomas: Insights from a Longitudinal Cohort Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsBilateral hemispheric involvement and inclusion of the corpus callosum; associated with poor prognosis (source needed).
Target Population
Care Setting

Key Highlights

  • Remove or source the claim about LITT enhancing immune activation.

Guideline-Based Recommendations

Diagnosis

    Management

    • C
    • o
    • n
    • s
    • i
    • d
    • e
    • r
    • L
    • I
    • T
    • T
    • f
    • o
    • r
    • p
    • a
    • t
    • i
    • e
    • n
    • t
    • s
    • w
    • i
    • t
    • h
    • s
    • u
    • r
    • g
    • i
    • c
    • a
    • l
    • l
    • y
    • i
    • n
    • a
    • c
    • c
    • e
    • s
    • s
    • i
    • b
    • l
    • e
    • b
    • u
    • t
    • t
    • e
    • r
    • f
    • l
    • y
    • g
    • l
    • i
    • o
    • m
    • a
    • s
    • (
    • s
    • o
    • u
    • r
    • c
    • e
    • n
    • e
    • e
    • d
    • e
    • d
    • )
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients undergoing biopsy or LITT for butterfly glioma.

        LITT procedures are performed via the same biopsy tract to minimize surgical access morbidity.

        Clinical Best Practices

        • Add sources for MRI-guided techniques and planning ablation corridors.

        Related Resources & Content

        Original Source(s)

        Butterfly gliomas: to biopsy or to ablate – a longitudinal cohort study

        • by Vratko Himic, Morgan Leigh Johnson, Anshul Ratnaparkhi, Roxanne C. Mayrand, Jay Chandar, Vaidya Govindarajan, Daniel C. Kreatsoulas, Arman Jahangiri, Zachary C. Gersey, Daniel M. Aaronson, Ricardo J. Komotar, Micheal E. Ivan, Ashish H. Shah

        • June 5, 2026

        Related Content

        Editorial: Innovative strategies in overcoming glioblastoma: advancements in treatment and research

        Development and validation of hypermethylated gene markers in cervical cytological samples for detecting endometrial cancer (EndoMethy-I trial)

        Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis